NCT00922701View on ClinicalTrials.gov

L-Carnitine in Peritoneal Dialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

December 31, 2004

Conditions
End-Stage Renal Disease
Interventions
DRUG

L-carnitine

Instillation of glucose-based (1.5% weight/volume) peritoneal dialysis solution containing L-carnitine (0.25% weight/volume) for the nocturnal exchange. Patients were treated with the experimental peritoneal dialysis solution for 5 days.

Trial Locations (1)

66013

"Division of Nephrology, University of G. d'Annunzio", Chieti

All Listed Sponsors
lead

Iperboreal Pharma Srl

INDUSTRY

NCT00922701 - L-Carnitine in Peritoneal Dialysis | Biotech Hunter | Biotech Hunter